CX3CL1 is involved in the migration of synovial fibroblasts and in angiogenesis, and its blockade using specific antibodies was found to reduce inflammatory cell infiltration and bone erosion in a murine RA model [48]. Here, CX3CL1 is linked to rheumatoid arthritis.